Clinical Trial Update: Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effect of oral 5-HTP on urinary 5-HIAA excretion was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Neuroendocrine Tumor

Drugs mentioned

• 5-HTP (5-hydroxytryptophan)

Snippet

Sponsor: University of Western Ontario, Canada | Conditions: Carcinoid Tumors, Neuroendocrine Tumors | Phase 3 | Status: TERMINATED